JN Macri Technologies Overview

  • Founded
  • 2003
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

JN Macri Technologies General Information


Provider of prenatal screening technology. The company holds and licenses global patents related to free beta Human Chorionic Gonadotropin ("free Beta hCG"). Free Beta hCG is a peptide hormone produced in the early stage of pregnancy that is recognized as a critical biomarker for first-trimester prenatal risk assessment.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Diagnostic Equipment
Primary Office
  • 403 Oakwood Road
  • Huntington Station, NY 11746
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

JN Macri Technologies Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore JN Macri Technologies‘s full profile, request access.

Request a free trial

JN Macri Technologies Patents

JN Macri Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-5252489-A Down syndrome screening method utilizing dried blood samples Expired - Lifetime 17-Jan-1989 000000000 0